Actively Recruiting
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
Led by National Institute on Alcohol Abuse and Alcoholism (NIAAA) · Updated on 2026-05-07
192
Participants Needed
1
Research Sites
548 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: Abusing alcohol, drugs, and other substances can cause serious health problems. These substances also can affect brain function. Researchers want to learn more about brain function by using magnetic resonance imaging (MRI). This uses a magnetic field and radio waves to take pictures of the brain. Objective: To develop new ways to use MRI to study the brain. Eligibility: Healthy people 18 years of age or older. Design: Participants will be screened with a medical history, physical exam, and blood and urine tests. They will answer questions about their drug use and psychiatric history. They will be asked about family history of alcoholism or drug abuse. Participants will answer questions to see if they can participate in MRI. Participants will have MRI scans. The scanner is a metal cylinder in a strong magnetic field. Participants will lie on a table that slides in and out of the cylinder. A device called a coil may be placed over the head. Each sub-study will include up to 3 different MRI visits. Participants can be in multiple sub-studies. But they can have only 1 MRI per week and 20 per year. During MRI visits, participants may have urine collected. They may get another MRI questionnaire. Participants may have a clinical MRI brain scan. This may show physical problems in the brain. During some scans, participants may perform simple movement, memory, and thinking tasks. Participants may be connected to a machine to monitor brain activity during the scan. Small metal electrodes will be placed on the scalp. A gel will be placed in the space between the electrodes and the scalp. ...
CONDITIONS
Official Title
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Eighteen years or older.
- Ability to provide written informed consent as determined by physical examination and verbal communication.
- Willingness to abstain from drug use on scheduled testing days.
You will not qualify if you...
- Positive urine pregnancy test in females.
- Presence of ferromagnetic objects contraindicated for MRI or fear of enclosed spaces.
- Claustrophobia.
- Body weight over 550 lbs.
- Current psychiatric disorder diagnosis (other than nicotine/caffeine use disorders).
- Past severe mental disorder requiring hospitalization or chronic medication.
- Monthly binge drinking for the last 10 years.
- Serious neurological disorders such as MS, Parkinson's Disease, ALS, sensory loss, or peripheral neuropathy.
- Current use of psychoactive drugs excluding caffeine and PRN medications.
- Clinically significant lab or exam results.
- Investigators, staff, and their immediate family members.
- Non-English speakers unable to read and comprehend English.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
Research Team
D
Dardo G Tomasi, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
9
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here